Therapeutic Potential of Autologous Adipose-Derived Stem Cells for the Treatment of Liver Disease
Open Access
- 15 December 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (12) , 4064
Abstract
Currently, the most effective therapy for liver diseases is liver transplantation, but its use is limited by organ donor shortage, economic reasons, and the requirement for lifelong immunosuppression. Mesenchymal stem cell (MSC) transplantation represents a promising alternative for treating liver pathologies in both human and veterinary medicine. Interestingly, these pathologies appear with a common clinical and pathological profile in the human and canine species; as a consequence, dogs may be a spontaneous model for clinical investigations in humans. The aim of this work was to characterize canine adipose-derived MSCs (cADSCs) and compare them to their human counterpart (hADSCs) in order to support the application of the canine model in cell-based therapy of liver diseases. Both cADSCs and hADSCs were successfully isolated from adipose tissue samples. The two cell populations shared a common fibroblast-like morphology, expression of stemness surface markers, and proliferation rate. When examining multilineage differentiation abilities, cADSCs showed lower adipogenic potential and higher osteogenic differentiation than human cells. Both cell populations retained high viability when kept in PBS at controlled temperature and up to 72 h, indicating the possibility of short-term storage and transportation. In addition, we evaluated the efficacy of autologous ADSCs transplantation in dogs with liver diseases. All animals exhibited significantly improved liver function, as evidenced by lower liver biomarkers levels measured after cells transplantation and evaluation of cytological specimens. These beneficial effects seem to be related to the immunomodulatory properties of stem cells. We therefore believe that such an approach could be a starting point for translating the results to the human clinical practice in future.Keywords
This publication has 88 references indexed in Scilit:
- Genetic and molecular control of osterix in skeletal formationJournal of Cellular Biochemistry, 2012
- Mesenchymal stem cells: a double-edged sword in regulating immune responsesCell Death & Differentiation, 2012
- In vitro expansion and differentiation of fresh and revitalized adult canine bone marrow-derived and adipose tissue-derived stromal cellsThe Veterinary Journal, 2012
- Prostaglandin E2 As an Inhibitory Modulator of Fibrogenesis in Human Lung AllograftsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Cell Therapies for Liver DiseasesLiver Transplantation, 2011
- Immunomodulatory properties and therapeutic application of mesenchymal stem cellsClinical and Experimental Immunology, 2011
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Transcriptional control of adipocyte formationCell Metabolism, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001